<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 20 KIDNEY DISEASE PROGRAM | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.20/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.20/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|20|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|20" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="http://regs.maryland.gov//us/md/exec/comar/10.20"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 20 KIDNEY DISEASE PROGRAM | Library of Maryland Regulations"/>
    <meta property="og:image" content="http://regs.maryland.gov//us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.20/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.20/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|20" data-search-heading="">
                  <span title="Subtitle 20 KIDNEY DISEASE PROGRAM">Subtitle 20 KIDNEY DISEASE PROGRAM</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|20">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.20">Subtitle 20 KIDNEY DISEASE PROGRAM</h1>
                <h2 id="/us/md/exec/comar/10.20.01" data-order="|10|20|01|" data-ref-path="10|20|01" class="h__chapter">Chapter 01 General Regulations</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date:</p>
                  <p>Chapter, Control of Noise Pollution, transferred to Title 26 Department of the Environment, June, 1988</p>
                  <p>——————</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.01" title=".01 Definitions.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.10" title=".10 Informal Reconsiderations and Hearings.">.10</a>, General Regulations (Kidney Disease Program), adopted as an emergency provision effective November 1, 1991 (18:23 Md. R. 2481); emergency status expired March 30, 1992</p>
                  <p>Regulations <a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.01" title=".01 Definitions.">.01</a> — <a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.10" title=".10 Informal Reconsiderations and Hearings.">.10</a> adopted effective March 31, 1992 (19:3 Md. R. 304)</p>
                  <p>——————</p>
                  <p>Chapter revised as an emergency provision effective November 29, 1999 (26:26 Md. R. 1958); revised permanently effective March 8, 2000 (27:4 Md. R. 454)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.01#B" title="">Regulation .01B</a> amended effective June 21, 2004 (31:12 Md. R. 912); April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.02#C" title="">Regulation .02C</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.03" title=".03 Recipient Eligibility and Certification for Program Participation.">Regulation .03</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.03#D" title="">Regulation .03D</a> amended effective February 12, 2007 (34:3 Md. R. 299)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.05#D" title="">Regulation .05D</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.07" title=".07 Provider Reimbursement.">Regulation .07</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.07#G" title="">Regulation .07G</a>, H amended effective June 21, 2004 (31:12 Md. R. 912)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.08" title=".08 Limitations.">Regulation .08</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.08#A" title="">Regulation .08A</a> amended effective February 12, 2007 (34:3 Md. R. 299)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.20.01.09#C" title="">Regulation .09C</a> amended effective April 4, 2011 (38:7 Md. R. 431)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§13-301 — 13-315 and 16-204, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.20.01.01" data-order="|10|20|01|.01|" data-ref-path="10|20|01|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(1)">(1)</span> "Applicant" means an individual who has applied for, or is in the process of applying for, Kidney Disease Program enrollment and has not yet been certified as an eligible recipient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(2)">(2)</span> "Certification period" means the 12-month period during which an individual is certified as eligible to receive Kidney Disease Program benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(3)">(3)</span> "Certified facility" means a hospital, dialysis facility, or transplantation center which the Department certifies meets the standards that the Commission adopts for providing services to recipients and which is certified by Medicare.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(4)">(4)</span> "Commission" means the State Commission on Kidney Disease.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(5)">(5)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(6)">(6)</span> "Dialysis" means chronic hemodialysis or chronic peritoneal dialysis provided in a certified facility or a facility approved by the Commission or in the patient's home under the auspices of a certified facility or home dialysis program approved by the Commission.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(7)">(7)</span> "End stage renal disease (ESRD)" means that stage of renal impairment that appears irreversible and permanent, and requires a regular course of maintenance dialysis or kidney transplantation to maintain life.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(8)">(8)</span> "Family" means the recipient and all of the following individuals sharing the same household with the recipient:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(8)(a)">(a)</span> The recipient's spouse;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(8)(b)">(b)</span> The recipient's natural or adopted children who are younger than 21 years old;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(8)(c)">(c)</span> The recipient's natural or adoptive parent, if the recipient is a child younger than 21 years old; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(8)(d)">(d)</span> The recipient's stepchildren or grandchildren for which the recipient has legal or presumed guardianship.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(9)">(9)</span> "Liquid assets" means cash or an asset that can readily be converted to cash.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(10)">(10)</span> "Medical Assistance" means the State program of comprehensive medical and other health-related care for indigent and medically indigent persons.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(11)">(11)</span> "Medicare" means the insurance program administered by the federal government under Title XVIII of the Social Security Act, 42 U.S.C. §1395 et seq.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(12)">(12)</span> "Poverty income guidelines" means the federal poverty income guidelines contained in the most recent annual update of the Department of Health and Human Services poverty income guidelines as published in the Federal Register.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(13)">(13)</span> "Preauthorization" means an approval required from the Program before services are rendered to a recipient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(14)">(14)</span> “Primary Adult Care Program (PAC)” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.60.02" title=".02 Eligibility, Enrollment, and Disenrollment.">COMAR 10.09.60.02</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(15)">(15)</span> "Program" means the Kidney Disease Program of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(16)">(16)</span> "Program participation fee" means an annual premium which may be assessed by the Program and is based on family income or liquid assets, or both.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(17)">(17)</span> "Provider" means an individual, association, partnership, corporation, or unincorporated group licensed or certified to provide health care services for Program recipients.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)">(18)</span> “Qualified alien” means an alien who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)(a)">(a)</span> Has been fully admitted for permanent residence in the United States under the Immigration and Nationality Act (INA);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)(b)">(b)</span> Has been granted asylum in the United States under §208 of the INA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)(c)">(c)</span> Has been admitted into the United States as a refugee under §207 of the INA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)(d)">(d)</span> Has been paroled into the United States under §212(d)(5) of the INA for a period of at least 1 year;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)(e)">(e)</span> Has had deportation withheld under §243(h) of the INA; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(18)(f)">(f)</span> Has been granted conditional entry into the United States under §203(a)(7) of the INA in effect before April 1, 1980.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(19)">(19)</span> "Quarterly amount" means the quarterly installment payment which is equal to 25 percent of a recipient's annual Program participation fee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(20)">(20)</span> "Recipient" means an individual who is certified for enrollment in the Kidney Disease Program of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(21)">(21)</span> "Reimbursable drug list" means the Kidney Disease Program formulary of medications approved for payment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(22)">(22)</span> "Representative" means an individual who, because of an applicant's or a recipient's mental or physical incapacity or youth, or specified dialysis or transplant facility personnel who have been so designated by virtue of the applicant's or recipient's voluntarily signed authorization form, is authorized, in accordance with State law, to complete, sign, or withdraw an application for enrollment in the Program or to activate a hearing process.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(23)">(23)</span> Resident.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(23)(a)">(a)</span> "Resident" means an individual permanently living in Maryland whose temporary absence from the State does not interrupt continuity of residence.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(23)(b)">(b)</span> "Resident" does not mean:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(23)(b)(i)">(i)</span> Members or their families, or both, of the United States armed services temporarily stationed in Maryland; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.01#B(23)(b)(ii)">(ii)</span> Foreign nationals employed in embassies of their native country.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.02" data-order="|10|20|01|.02|" data-ref-path="10|20|01|.02" class="h__section">.02 Program Application Process.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#A">A.</span> A Maryland resident diagnosed with end-stage renal disease may apply for certification with the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#B">B.</span> An applicant, or the applicant's representative, shall complete a written application on the form designated by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C">C.</span> Application Supporting Documents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)">(1)</span> The Program may require the following as part of the application form or in addition to the application form:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(a)">(a)</span> Copies of the previous year's federal income tax return of the applicant and each individual in the applicant's family;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(b)">(b)</span> Current statements of liquid assets owned by the applicant and each individual in the applicant's family;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(c)">(c)</span> The amount of the current Social Security benefits and all retirement or pension benefits, or both, of the applicant and each individual in the applicant's family;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(d)">(d)</span> Documentation of the applicant’s identity as well as citizenship or nationality, to the Department’s satisfaction, based on federal requirements;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(e)">(e)</span> Verification of the applicant's status as a resident of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(f)">(f)</span> Verification of the applicant’s Medicare status;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(g)">(g)</span> Verification concerning the applicant's enrollment in any health insurance benefit plan;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(h)">(h)</span> Physician's certification that the applicant has ESRD;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(i)">(i)</span> Physician's certification that the applicant has begun a regular course of maintenance renal dialysis in a certified facility or received a renal transplant, or both;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(j)">(j)</span> A signed statement authorizing the Program to verify, from any source including banks, insurance companies, and public or private agencies providing monetary benefits, information submitted to the Program by the applicant; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(1)(k)">(k)</span> Other information the Program determines is needed to establish whether  the applicant is eligible to be a recipient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(2)">(2)</span> Refusal to sign an authorization that may be required under <a class="internal-link " href="/us/md/exec/comar/10.20.01.02#C(1)(j)" title="">§C(1)(j) of this regulation</a> is considered failure to provide sufficient information, and the applicant will be determined ineligible without prejudice in accordance with <a class="internal-link " href="/us/md/exec/comar/10.20.01.02#F" title="">§F of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#C(3)">(3)</span> In reference to <a class="internal-link " href="/us/md/exec/comar/10.20.01.02#C(1)(a)" title="">§C(1)(a) of this regulation</a>, the Program may accept the previous year's tax return through April 15 of the year in which an application for certification is filed. After April 15, the Program requires the new tax return or proof of extension granted for filing a return.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#D">D.</span> Signature Requirements.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#D(1)">(1)</span> For the purpose of establishing eligibility, the applicant or the applicant's representative, as appropriate, shall complete and sign the application form.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#D(2)">(2)</span> A physician shall sign the certification that the applicant has ESRD and has begun a regular course of maintenance renal dialysis, or has received a renal transplant, or both.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#E">E.</span> The applicant or the applicant's representative shall forward the completed application form and supporting documents to the address designated on the form.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#F">F.</span> An applicant shall provide all required information within 90 days from the date the information is originally requested by the Program or the applicant shall be determined ineligible without prejudice and may reapply.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#G">G.</span> The applicant, or the applicant's representative, may voluntarily withdraw an application at any time without prejudice.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#H">H.</span> If the Program determines that an applicant is not eligible for Program enrollment, the Program shall notify the applicant or the applicant's representative, as appropriate, in writing within 45 days of receipt of a completed application and include the following in the notice:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#H(1)">(1)</span> The basis for the determination of ineligibility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#H(2)">(2)</span> An explanation of the right to request a hearing; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#H(3)">(3)</span> A statement that the applicant is permitted to submit a new application for Program enrollment at any time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#I">I.</span> If the Program determines that an applicant is eligible for Program enrollment, the Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#I(1)">(1)</span> Establish a certification period in accordance with <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#C" title="">Regulation .03C of this chapter</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#I(2)">(2)</span> Notify the applicant or the applicant's representative, as appropriate, in writing within 45 days of receipt of a completed application;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#I(3)">(3)</span> Issue a Kidney Disease Program recipient identification card and instructions for using the card; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.02#I(4)">(4)</span> Notify the applicant or the applicant's representative, as appropriate, about any Program participation fee due in accordance with <a class="internal-link " href="/us/md/exec/comar/10.20.01.04" title=".04 Program Participation Fee.">Regulation .04 of this chapter</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.03" data-order="|10|20|01|.03|" data-ref-path="10|20|01|.03" class="h__section">.03 Recipient Eligibility and Certification for Program Participation.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A">A.</span> To be eligible for enrollment in the Program an applicant shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)">(1)</span> Be a resident of Maryland and one of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)(a)">(a)</span> A citizen of the United States,</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)(b)">(b)</span> A qualified alien, as specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#C" title="">§C of this regulation</a>, who is eligible in accordance with the requirements related to the 5-year bar specified at <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#D" title="">§D of this regulation</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)(c)">(c)</span> An alien who is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)(c)(i)">(i)</span> Eligible for and receiving Supplemental Security Income (SSI);</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)(c)(ii)">(ii)</span> A member of a federally recognized Indian tribe, as defined in 25 U.S.C. §450b(e); or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(1)(c)(iii)">(iii)</span> An American Indian born in Canada to whom §289 of the Immigration and Nationality Act (INA) applies.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(2)">(2)</span> Be certified by a physician as having end stage renal disease;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(3)">(3)</span> Meet one of the following requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(3)(a)">(a)</span> Have begun a regular course of maintenance renal dialysis in a certified facility or have received a renal transplant, or both; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(3)(b)">(b)</span> Have begun a course of maintenance renal dialysis in an out-of-State facility when the Program has preauthorized the treatment based on the facility's proximity to the applicant's residence or to assure continuity of care, or both; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#A(4)">(4)</span> Submit an application in accordance with <a class="internal-link " href="/us/md/exec/comar/10.20.01.02" title=".02 Program Application Process.">Regulation .02 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#B">B.</span> An individual detained by a federal, state, or local penal or correctional system as a result of a charge, indictment, or conviction of a criminal offense is not eligible for Program enrollment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C">C.</span> Qualified Aliens. According to §431 of the Personal Responsibility and Work Opportunity and Reconciliation Act of 1996 (PRWORA), qualified aliens admitted to the United States shall include:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)">(1)</span> The following types of aliens, who may be subject to the 5-year bar specified at <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#D" title="">§D of this regulation</a>, depending on their most recent date of entry and their date of qualified alien status:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(a)">(a)</span> Aliens who were lawfully admitted to the United States for permanent residence or who since admission were granted lawful permanent resident status in accordance with the INA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(b)">(b)</span> Aliens granted parole for at least 1 year under §212(d)(5) of the INA; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(c)">(c)</span> A documented or undocumented immigrant who was battered or subjected to extreme cruelty by the individual’s United States citizen or lawful permanent resident spouse or parent, or by a member of the spouse’s or parent’s family residing in the same household as the immigrant, if:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(c)(i)">(i)</span> The spouse or parent consented to, or acquiesced in, the battery or cruelty;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(c)(ii)">(ii)</span> The abusive act or acts occurred in the United States;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(c)(iii)">(iii)</span> The individual responsible for the battery or cruelty no longer lives in the same household as the victim;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(c)(iv)">(iv)</span> A Violence Against Women Act immigration case or a family-based visa petition has been filed; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(1)(c)(v)">(v)</span> There is a substantial connection between the battery or cruelty and the need for Medical Assistance benefits; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)">(2)</span> The following types of aliens, who are not subject to the 5-year bar specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#D" title="">§D of this regulation</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(a)">(a)</span> Alien children and pregnant women who are lawfully residing in the United States, including legal permanent residents who have resided in the United States for less than 5 years as described under §214 of the Children’s Health Insurance Program Authorization Act of 2009 (CHIPRA);</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(b)">(b)</span> Aliens who were lawfully admitted to the United States for permanent residence as Amerasian immigrants under §584 of the Foreign Operations, Export Financing and Related Programs Appropriations Act of 1988;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(c)">(c)</span> Refugees admitted under §207 of the INA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(d)">(d)</span> Aliens granted asylum under §208 of the INA;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(e)">(e)</span> Aliens whose deportation is being withheld under:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(e)(i)">(i)</span> §243(h) of the INA as in effect prior to April 1, 1997; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(e)(ii)">(ii)</span> §241(b)(3) of the INA, as amended;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(f)">(f)</span> Cuban or Haitian entrants, as defined at §501(e) of the Refugee Education Assistance Act of 1980;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(g)">(g)</span> Aliens granted conditional entry under §203(a)(7) of the INA in effect before April 1, 1980;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(h)">(h)</span> Children receiving federal payments for foster care or adoption assistance under Part B or E of Title IV of the Social Security Act, if the child’s foster or adoptive parent is considered a citizen or qualified alien; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(i)">(i)</span> Victims of a severe form of trafficking, in accordance with §107(b)(1) of the Trafficking Victims Protection Act of 2000, who have been subjected to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(i)(i)">(i)</span> Sex trafficking if the act is induced by force, fraud, or coercion, or the individual who was induced to perform the act was younger than 18 years old on the date that the visa application was filed; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#C(2)(i)(ii)">(ii)</span> Involuntary servitude.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D">D.</span> Five-Year Bar to Program Benefits for Qualified Aliens.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(1)">(1)</span> Qualified aliens in the categories specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#C(1)" title="">§C(1) of this regulation</a> who entered the United States on or after August 22, 1996, were not eligible for Program benefits for 5 years from the date that the qualified alien:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(1)(a)">(a)</span> Entered the United States with the status of a qualified alien; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(1)(b)">(b)</span> Obtained the status of a qualified alien, if the individual did not enter the United States as a qualified alien.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(2)">(2)</span> The 5-year bar specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#D(1)" title="">§D(1) of this regulation</a> shall also be applied to qualified aliens who entered the United States before August 22, 1996, but did not remain continuously present in the United States from the last date of entry before August 22, 1996 until the date of qualified alien status.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(3)">(3)</span> An alien is not considered to be continuously present in the United States as specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#D(2)" title="">§D(2) of this regulation</a> if, before the date of qualified alien status, the alien had:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(3)(a)">(a)</span> A single absence from the United States of more than 30 days; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(3)(b)">(b)</span> Absences from the United States totaling more than 90 days.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)">(4)</span> The 5-year bar to eligibility for Program benefits, specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#D(1)" title="">§D(1) of this regulation</a>, does not apply to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(a)">(a)</span> Qualified aliens in the categories specified at:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(a)(i)">(i)</span> <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#C(1)" title="">§C(1) of this regulation</a>, who are not subject to the 5-year bar in accordance with §D(1) or (2) of this regulation; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(a)(ii)">(ii)</span> <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#C(2)" title="">§C(2) of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(b)">(b)</span> A qualified alien who is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(b)(i)">(i)</span> An honorably discharged veteran of the armed forces of the United States;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(b)(ii)">(ii)</span> On active duty in the armed forces of the United States; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(b)(iii)">(iii)</span> The lawfully admitted spouse, including a surviving spouse who has not remarried, or lawfully admitted unmarried dependent child of an honorably discharged veteran or individual on active duty in the armed forces of the United States; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(c)">(c)</span> Lawful permanent residents who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(c)(i)">(i)</span> Entered the United States under another exempt category specified at §D(4)(a) — (b) of this regulation; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#D(4)(c)(ii)">(ii)</span> Converted to lawful permanent resident status.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#E">E.</span> Certification Period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#E(1)">(1)</span> The Program shall establish the certification period during which an individual is eligible to receive Program benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#E(2)">(2)</span> The certification period shall be retroactive to the first day of maintenance renal dialysis or renal transplantation if a completed application is received by the Program within 30 days after the first day of maintenance renal dialysis, or within 30 days after renal transplantation, whichever treatment occurs first.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#E(3)">(3)</span> If a completed application is received by the Program more than 30 days after the first day of maintenance renal dialysis, or more than 30 days after the date of renal transplantation, whichever treatment occurs first, the certification period shall begin on the first day of the month in which the completed application is received by the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#E(4)">(4)</span> The Program shall certify a recipient for a 12-month period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#E(5)">(5)</span> The Program shall promptly redetermine eligibility when it receives information concerning a recipient's circumstances that may affect continuing eligibility.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F">F.</span> A recipient shall comply with the following requirements to continue Program enrollment throughout a certification period:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(1)">(1)</span> Unless a recipient can document continuing insurance coverage that is equal to or greater than Medicare benefits, apply for enrollment in Part A, Part B, and Part D of Medicare within 60 days of notification to do so by the Program, if not already a Medicare beneficiary;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(2)">(2)</span> Apply for enrollment in Part A, Part B, and Part D of Medicare within 60 days following termination of insurance coverage that is equal to or greater than Medicare benefits;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(3)">(3)</span> Maintain enrollment in Part A, Part B, and Part D of Medicare if eligible;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(4)">(4)</span> Apply for enrollment in Medical Assistance within 60 days of notification to do so by the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(5)">(5)</span> Maintain enrollment in Medical Assistance if eligible;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(6)">(6)</span> Continue to meet the requirements of §§A and I of this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(7)">(7)</span> Reimburse the Department any monies received from any insurance company or other third party for payment of ESRD treatment costs previously reimbursed by the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#F(8)">(8)</span> Pay the Program participation fee, if applicable, in accordance with <a class="internal-link " href="/us/md/exec/comar/10.20.01.04" title=".04 Program Participation Fee.">Regulation .04 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#G">G.</span> A recipient is considered to have failed to meet the requirement of <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#F(4)" title="">§F(4) of this regulation</a> if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#G(1)">(1)</span> The recipient fails to provide information required for certification or recertification of Medical Assistance eligibility; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#G(2)">(2)</span> Medical Assistance disenrolls the recipient because of recipient fraud, recipient abuse, or recipient failure to comply with reporting requirements.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#H">H.</span> Reapplication for Continuation of Certification.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#H(1)">(1)</span> The Program shall notify the recipient in writing 60 days before an annual certification period expires.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#H(2)">(2)</span> A recipient shall complete a written application for continuation of certification for Program benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#H(3)">(3)</span> A recipient shall be disenrolled from the Program upon expiration of a certification period unless the Program receives a completed application for continuation of certification 30 days before expiration of a certification period.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#I">I.</span> The recipient shall notify the Program within 30 working days of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#I(1)">(1)</span> A payment received from any source that is related to treatment of the recipient's ESRD;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#I(2)">(2)</span> The recipient's regaining renal function;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#I(3)">(3)</span> A change in address; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#I(4)">(4)</span> A change in State residence, citizenship, or alien status.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J">J.</span> Termination Before Expiration of Certification Period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)">(1)</span> The Program shall terminate a recipient’s enrollment in the Program before expiration of the current certification period if the recipient:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(a)">(a)</span> Fails to provide the notice required by <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#I" title="">§I of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(b)">(b)</span> Voluntarily disenrolls;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(c)">(c)</span> No longer meets the medical requirements for participation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(d)">(d)</span> No longer meets the residence, citizenship, or alien status requirements of <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#A(1)" title="">§A(1) of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(e)">(e)</span> Fails to pay the Program participation fee described in <a class="internal-link " href="/us/md/exec/comar/10.20.01.04" title=".04 Program Participation Fee.">Regulation .04 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(f)">(f)</span> Fails to apply for and maintain enrollment in Medicare, if eligible;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(g)">(g)</span> Fails to apply for and maintain enrollment in the Medical Assistance Program if required by the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(h)">(h)</span> Fails to pay the Department any monies received from any source for payment of ESRD treatment costs previously reimbursed by the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(i)">(i)</span> Has not received a kidney transplant but no longer requires a regular course of maintenance dialysis, 12 months after the date on which the course of dialysis is terminated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(j)">(j)</span> Is incarcerated by a federal, state, or local penal or correctional system;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(k)">(k)</span> Has used the Program identification number to fraudulently obtain goods or services, or permits another individual to use the Program identification number to fraudulently obtain goods or services;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(l)">(l)</span> Fails to pay the quarterly amount within the required time frame and the Program has not paid for any services provided for the recipient within the quarter; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(1)(m)">(m)</span> Has died.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#J(2)">(2)</span> Pursuant to <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#J(1)(l)" title="">§J(1)(l) of this regulation</a>, termination is considered voluntary withdrawal and becomes effective retroactive to the first day of the quarter billed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K">K.</span> Continuing Certification and Termination Notices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(1)">(1)</span> The Program shall inform a recipient, or the recipient's representative, of the recipient's rights and obligations regarding continuing certification and termination of Program enrollment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)">(2)</span> The Program shall give the recipient or the recipient’s representative written notification of the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)(a)">(a)</span> That a certification period is due to expire and reapplication is required as set forth in <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#H" title="">§H of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)(b)">(b)</span> The effective date of termination of Program enrollment when:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)(b)(i)">(i)</span> The recipient no longer meets the residence, citizenship, or alien status requirements;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)(b)(ii)">(ii)</span> The recipient is incarcerated; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)(b)(iii)">(iii)</span> The recipient has died; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(2)(c)">(c)</span> The Program’s intent to terminate the recipient’s enrollment for reasons other than those set forth in §K(2)(a) and (b) of this regulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(3)">(3)</span> A notice that the certification period is about to expire or of the Program's intent to terminate the recipient's enrollment due to the recipient's failure to apply for recertification or to pay the assessed quarterly premium shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(3)(a)">(a)</span> Be mailed at least 30 calendar days before the date on which the action is to be effective;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(3)(b)">(b)</span> Include a statement of the proposed actions, the reasons for the action, and the regulatory citation supporting the action; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#K(3)(c)">(c)</span> Include an explanation of the right to request a hearing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.03#L">L.</span> If the Program determines that the recipient has used the Program identification number to fraudulently obtain goods or services, or has permitted another individual to use the Program identification number to fraudulently obtain goods or services, and certification is terminated pursuant to <a class="internal-link " href="/us/md/exec/comar/10.20.01.03#J(1)(k)" title="">§J(1)(k) of this regulation</a>, the recipient is not eligible to reapply for Program certification.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.04" data-order="|10|20|01|.04|" data-ref-path="10|20|01|.04" class="h__section">.04 Program Participation Fee.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#A">A.</span> A recipient whose family income exceeds 175 percent of the poverty income guidelines or whose family liquid assets exceed 200 percent of the poverty income guidelines, or both, at the time of initial application or reapplication is required to pay an annual Program participation fee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#B">B.</span> Family income for purposes of this regulation includes the adjusted gross income, as defined in the Internal Revenue Code for federal income tax purposes, plus Social Security benefits, all pension or retirement benefits, or both, and all interest income not otherwise included in the adjusted gross income for federal income tax purposes, of the recipient and each person in the recipient's family.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#C">C.</span> The Program shall establish a recipient's annual Program payment fee equal to the sum of:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#C(1)">(1)</span> 5 percent of the amount by which the family income exceeds 175 percent of the poverty income guidelines adjusted for family size; plus</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#C(2)">(2)</span> 5 percent of the family's liquid assets above 200 percent of the poverty income guidelines adjusted for family size.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D">D.</span> For purposes of <a class="internal-link " href="/us/md/exec/comar/10.20.01.04#C(2)" title="">§C(2) of this regulation</a>, the Program shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(1)">(1)</span> Include assets which are available as of the date of application for initial enrollment or certification of continuing enrollment, as applicable, in the family's liquid assets;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)">(2)</span> Include the following in the family's liquid assets:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(a)">(a)</span> Cash;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(b)">(b)</span> Savings and checking accounts;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(c)">(c)</span> Certificates of deposit;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(d)">(d)</span> Stocks;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(e)">(e)</span> Bonds;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(f)">(f)</span> Life insurance cash value exceeding $1,500;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(g)">(g)</span> Mutual funds;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(h)">(h)</span> Money market certificates; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(2)(i)">(i)</span> Other financial instruments or investments that can readily be converted to cash; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(3)">(3)</span> Exclude the following from the family's liquid assets:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(3)(a)">(a)</span> Items of real property; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#D(3)(b)">(b)</span> Items of personal property.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E">E.</span> Collection of Fees.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(1)">(1)</span> The Department shall collect the annual Program participation fee in quarterly installments.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(2)">(2)</span> The Program shall notify the recipient of the amount of the annual Program participation fee, the quarterly amount to be paid, the payment due date, and payment procedures.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(3)">(3)</span> The Program may revise the amount of the Program participation fee during a certification period if the Program determines that a revision should be made because of a change in:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(3)(a)">(a)</span> Family income;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(3)(b)">(b)</span> Family liquid assets; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(3)(c)">(c)</span> Composition of the family unit.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(4)">(4)</span> The recipient shall have a grace period lasting from the first day of the quarter until 30 days before the end of the quarter in which to pay the quarterly amount.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(5)">(5)</span> The recipient's enrollment in the Program shall be terminated on the last day of the quarter if a fee amount is not paid by the end of the grace period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(6)">(6)</span> The recipient is responsible for the assessed quarterly amount if the Program receives claims and makes payment for services provided for the recipient within the quarterly billing period.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(7)">(7)</span> The Program shall extend the grace period for up to 6 months when the Program determines that, due to extraordinary medical expenses paid by the recipient, a change in family income, or frequent or extended hospitalizations, payment within the grace period will cause substantial hardship to the recipient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(8)">(8)</span> The Department may not refund the Program participation fee paid when the recipient’s Program enrollment is terminated unless termination occurs before the start of the quarter for which the Program participation fee was paid.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(9)">(9)</span> Before the Program will recertify an applicant whose prior Program enrollment was terminated for failure to pay the Program participation fee in accordance with this regulation, the applicant shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(9)(a)">(a)</span> Pay any unpaid fees owing for all prior enrollment periods during which the applicant was enrolled in the Program; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.04#E(9)(b)">(b)</span> Make advance payment of the first quarterly installment of the Program participation fee established for the subsequent enrollment period.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.05" data-order="|10|20|01|.05|" data-ref-path="10|20|01|.05" class="h__section">.05 Preauthorization.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#A">A.</span> The following procedures or services require preauthorization:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#A(1)">(1)</span> Treatment that is provided outside of Maryland;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#A(2)">(2)</span> Pre-renal transplant dental services;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#A(3)">(3)</span> Ancillary supplies for home intravenous antibiotic therapy;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#A(4)">(4)</span> Durable medical equipment and disposable medical supplies used in the home; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#A(5)">(5)</span> One pair of eyeglasses, one time only.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#B">B.</span> The Program may preauthorize services when the provider submits to the Program adequate documentation demonstrating that the service to be preauthorized is directly related to treatment of the recipient's ESRD.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#C">C.</span> Renal transplantation services provided to a recipient outside of Maryland are not eligible for reimbursement unless the Commission gives prior written approval for the transplant.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#D">D.</span> The Program does not cover:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#D(1)">(1)</span> Any service denied by Medicare as not medically justified or any services covered by Medical Assistance; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#D(2)">(2)</span> Services which are investigational or experimental.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.05#E">E.</span> In cases of multiple organ transplants, Program coverage shall be limited to only those services related to transplantation of the kidney. The provider shall break out and satisfactorily document the charges related to the kidney transplant before submitting a reimbursement request to the Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.06" data-order="|10|20|01|.06|" data-ref-path="10|20|01|.06" class="h__section">.06 License Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.06#A">A.</span> A pharmacy may not qualify as a provider without first having obtained a permit from the Department pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, or from the appropriate agency in the state in which the pharmacy is located.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.06#B">B.</span> A pharmacy that provides compounded prescriptions for home intravenous therapy shall be licensed under the provisions of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34.19" title="Chapter 19 Sterile Pharmaceutical Compounding">COMAR 10.34.19</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.06#C">C.</span> A doctor of medicine or osteopathy shall be licensed and legally authorized to practice medicine and surgery, and to dispense drugs in the state in which the service is provided.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.07" data-order="|10|20|01|.07|" data-ref-path="10|20|01|.07" class="h__section">.07 Provider Reimbursement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#A">A.</span> To qualify as a provider, a pharmacy shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#A(1)">(1)</span> Maintain a permit from the Department pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, or from the appropriate agency in the state in which the pharmacy is located;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#A(2)">(2)</span> To the extent required by law, be licensed and legally authorized to practice or deliver services in the state in which the service is provided; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#A(3)">(3)</span> Be a provider in the Maryland Medical Assistance Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#B">B.</span> The Program shall reimburse for treatment directly related to a recipient's ESRD or a condition that is a direct result of the recipient's ESRD.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#C">C.</span> The Program shall reimburse the incurred costs of prescription drugs and other pharmaceutical products determined to be medically necessary by the recipient's physician for treatment directly related to the recipient's ESRD or a condition that is a direct result of the recipient's ESRD.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#D">D.</span> Before invoicing the Program, providers of Program-approved services shall first seek reimbursement from all other payment sources of the recipient including, but not limited to, insurance coverage, Medicare, Medical Assistance, and PAC. If the other sources reject a claim or pay less than the amount allowed by the Program, the provider may then submit the claim to the Program for review.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#E">E.</span> A pharmacy provider may invoice the Program for reimbursement of legend drugs covered through the major medical component of a recipient's third-party insurance. The Program shall then seek reimbursement from the recipient's major medical coverage.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#F">F.</span> When a recipient who is a Medicare beneficiary is provided a service that is covered by Medicare and the Program, Program payment shall be limited to payment of the recipient's Medicare deductible and co-insurance amounts.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#G">G.</span> The Program may not reimburse for Medical Assistance covered services if the recipient is a Medical Assistance recipient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#H">H.</span> When a service is covered by a recipient's health insurance plan under which the provider agrees to accept payment by the health insurance plan as payment in full for the service, payment may not be made by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#I">I.</span> The Program may not make a direct payment to a recipient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#J">J.</span> Program reimbursement for outpatient dialysis treatment shall be consistent with the limits established and rates paid by Medicare.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#K">K.</span> Program reimbursement for other than outpatient dialysis treatment shall be consistent with the limits established and rates or fees paid by the Maryland Medical Assistance Program for the service except as otherwise indicated in this regulation. For services reimbursed on a fee basis, only the Medical Assistance net reimbursement amount will be paid.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#L">L.</span> Reimbursement for preauthorized out-of-State renal transplantation services may not exceed rates paid for the same or similar services in Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M">M.</span> Program reimbursement for pharmacy services is as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(1)">(1)</span> The Program shall only pay for legend drugs and diabetic supplies itemized on the Kidney Disease Program of Maryland Reimbursable Drug List;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(2)">(2)</span> A pharmacy provider shall charge the Program the provider’s usual and customary charge to the general public for legend drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)">(3)</span> Drugs shall be reimbursed by the Program as follows:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(a)">(a)</span> Program payment for a legend drug shall be the lower of the provider's charge or the Medical Assistance allowable cost for the drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(b)">(b)</span> In addition to payment for the legend drug ingredient cost, the Program shall establish and pay a dispensing fee for legend drugs;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(c)">(c)</span> Duration of coverage for immunosuppressant drugs shall be consistent with Medicare policy;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(d)">(d)</span> The Program shall only pay for a generic equivalent unless a brand is specified as medically necessary by the prescribing physician;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(e)">(e)</span> The Program may not pay for more than a 34-day supply of an approved drug during a 26-day period;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(f)">(f)</span> The Program may not pay for replacement of lost medications;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(g)">(g)</span> The Program may pay for replacement of stolen medications when the claim is accompanied by a police report;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(h)">(h)</span> A pharmacy provider shall maintain on file a hard copy of each prescription filled for a recipient; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#M(3)(i)">(i)</span> The Program may not pay for legend drugs which are not FDA approved for the prescribed usage or which the FDA has declared to be “less-than-effective”.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#N">N.</span> Reimbursement for Epogen (Epoetin alfa), dispensed as part of the dialysis procedure, shall be consistent with Medicare rates. Reimbursement shall be limited to dialysis facilities.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#O">O.</span> Reimbursement for Procrit (Epoetin alfa) shall be consistent with Medicare rates. Coverage is limited to active renal transplant recipients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#P">P.</span> The Program shall provide reimbursement for access surgery required by a recipient for dialysis treatment even though the access surgery may predate the recipient's date of certification for Program benefits as established in accordance with <a class="internal-link " href="/us/md/exec/comar/10.20.01.03" title=".03 Recipient Eligibility and Certification for Program Participation.">Regulation .03 of this chapter</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q">Q.</span> To receive reimbursement from the Program a provider shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(1)">(1)</span> Accept payment by the Program as payment in full and make no additional charge to any person for services covered by the Program;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(2)">(2)</span> Provide services without regard to race, color, age, sex, national origin, marital status, or physical or mental handicap;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(3)">(3)</span> Verify the recipient's Program eligibility each time a service is provided by viewing the recipient's Kidney Disease Program identification card with a valid through date;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(4)">(4)</span> Notify the Program immediately of any recipient or provider activity or circumstance that affects eligibility, benefits, or reimbursement;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(5)">(5)</span> Maintain the confidentiality of all recipient information;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(6)">(6)</span> Submit the request for payment for services rendered according to procedures established by the Program and in the form designated by the Program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(7)">(7)</span> Maintain and make available administrative and medical records in accordance with the following requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(7)(a)">(a)</span> Administrative and medical records shall contain documentation that is sufficient in quantity, scope, and detail to confirm that services are provided in accordance with this chapter;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(7)(b)">(b)</span> Records shall be maintained for a minimum of 6 years; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.07#Q(7)(c)">(c)</span> Records shall be made available on request to the Department or the Department's designee.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.08" data-order="|10|20|01|.08|" data-ref-path="10|20|01|.08" class="h__section">.08 Limitations.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.08#A">A.</span> The Program does not cover a drug if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.08#A(1)">(1)</span> The manufacturer has not provided the same rebate to the Kidney Disease Program as that provided for State-Only Pharmacy Assistance recipients’ purchases of drugs as is required under §1927(c) of Title XIX of the Social Security Act (42 U.S.C. §1396r-8(c));</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.08#A(2)">(2)</span> The Program has provided notice to the manufacturer of the manufacturer’s failure to provide adequate rebates and its opportunity to request a waiver from the rebate requirement under <a class="internal-link " href="/us/md/exec/comar/10.20.01.08#A(3)" title="">§A(3) of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.08#A(3)">(3)</span> The manufacturer has failed to demonstrate to the Secretary that the drug's availability is essential to Kidney Disease Program recipients.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.08#B">B.</span> Effective April 4, 2012, a manufacturer or its designee may not dispute or request repayment of any rebate paid under <a class="internal-link " href="/us/md/exec/comar/10.20.01.08#A(1)" title="">§A(1) of this regulation</a> more than 1 year after the date the rebate was paid.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.09" data-order="|10|20|01|.09|" data-ref-path="10|20|01|.09" class="h__section">.09 Payment Procedures.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#A">A.</span> A provider shall submit the request for Program payment for services rendered to a recipient according to procedures established by the Program and in the form designated by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#B">B.</span> The Program reserves the right to return to the provider, before payment, all invoices not properly signed, completed, and accompanied by properly completed forms required by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#C">C.</span> Billing Time Limits.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#C(1)">(1)</span> The Program may not make payments for an invoice that the Program receives more than 6 months from the date of service, except for an invoice first submitted to Medicare, a health insurer, or other third party for reimbursement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#C(2)">(2)</span> For an invoice initially submitted to a third party for payment, the Program may not make payment unless the Program receives the invoice within 6 months of the date of service or 3 months of the third party's notification of payment action to the provider, whichever is later.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#C(3)">(3)</span> The Program shall make payment on a claim which the Program returns to the provider due to improper completion or incomplete information only if the claim is properly completed, resubmitted, and received by the Program within the original 6 months, or within 3 months of being returned, whichever is later.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#C(4)">(4)</span> If Medicare, or a third party rejects a provider’s claim because the claim was not received within the third party’s billing time limits, the Program may not make payment on that claim.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.09#C(5)">(5)</span> If the Program denies payment due to late billing, a provider may not recover the amount later from either the recipient or the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.10" data-order="|10|20|01|.10|" data-ref-path="10|20|01|.10" class="h__section">.10 Informal Reconsiderations and Hearings.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A">A.</span> Informal Reconsideration.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(1)">(1)</span> An applicant, recipient, or provider dissatisfied with a decision, action, or inaction of the Department under this chapter shall be granted an opportunity for an informal reconsideration of the matter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(2)">(2)</span> The informal reconsideration shall include:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(2)(a)">(a)</span> Written notice to the applicant, recipient, or provider of the decision or action taken by the Department and the basis for the decision or action;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(2)(b)">(b)</span> If applicable, a written description of the basis for the Department's inaction;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(2)(c)">(c)</span> A reasonable opportunity for the applicant, recipient, or provider to refute the basis of the Department's decision, action, or inaction; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(2)(d)">(d)</span> A written affirmation or reversal of the Department's decision, action, or inaction.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(3)">(3)</span> The opportunity to refute the Department's decision, action, or inaction specified in <a class="internal-link " href="/us/md/exec/comar/10.20.01.10#A(2)(c)" title="">§A(2)(c) of this regulation</a> may be provided:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(3)(a)">(a)</span> In a meeting with a representative of the Program at the offices of the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(3)(b)">(b)</span> By telephone conference; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#A(3)(c)">(c)</span> In writing.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B">B.</span> Hearings.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B(1)">(1)</span> The Department shall grant an opportunity for a hearing to an applicant or recipient who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B(1)(a)">(a)</span> Is determined to be ineligible for benefits under the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B(1)(b)">(b)</span> Is terminated from enrollment in the Program; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B(1)(c)">(c)</span> Is otherwise denied benefits under the Program due to a decision, action, or inaction of the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B(2)">(2)</span> An applicant or recipient requesting a hearing shall notify the Department of the request within 30 days of the date of receipt of the notice of final decision or intended action by the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.10#B(3)">(3)</span> Hearings shall be conducted in accordance with <a class="internal-link no-wrap" href="/us/md/exec/comar/10.01.03" title="Chapter 03 Procedures for Hearings Before the Secretary of Health">COMAR 10.01.03</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.11" data-order="|10|20|01|.11|" data-ref-path="10|20|01|.11" class="h__section">.11 Program Recovery and Reimbursement.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#A">A.</span> The Department shall seek recovery in all cases when Program benefits have been incorrectly paid.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#B">B.</span> The Department shall accept reimbursement when voluntarily offered by a current or former recipient or someone acting on the recipient's behalf.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#C">C.</span> The Department may institute any proceedings that the Department considers necessary to require collection of uncollected fees.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#D">D.</span> The Program shall refer to the Central Collection Unit in the Department of Budget and Fiscal Planning for investigation and other appropriate action all cases in which a recipient has received coverage erroneously as a result of the action or inaction of the recipient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#E">E.</span> The Department shall investigate and take appropriate action in all cases in which eligibility has been incorrectly established as a result of the action or inaction of a recipient, representative, or person acting responsibly for the recipient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#F">F.</span> The Program shall require a recipient to authorize the release to the Department of all data, records, and information by insurance companies, nonprofit health service plans, providers of medical care, employers, unions, governmental agencies, and any other agencies, organizations, or individuals necessary for the Department's pursuit of third-party reimbursement. The authorization extends to all information relevant to third-party reimbursement or third-party health care coverage.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#G">G.</span> The Department shall collect available benefits from third parties determined liable to pay for services received under the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#H">H.</span> A recipient who receives medical services that were or will be paid for by the Program is considered to have made assignment to the Department of the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#H(1)">(1)</span> Recipient's rights to any third-party payments for medical care; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#H(2)">(2)</span> Rights of any other individual eligible under the plan, for whom the recipient can legally make an assignment.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#I">I.</span> The assignment created under <a class="internal-link " href="/us/md/exec/comar/10.20.01.11#H" title="">§H of this regulation</a> shall be effective as long as the recipient is enrolled in the Program and remains effective for all services paid by the Program during this period of enrollment, and for those services which were erroneously provided to ineligible persons and paid for by the Program.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#J">J.</span> If a recipient dies, the Department may make a claim against the estate of the recipient for any unpaid fee established for that recipient in accordance with the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#J(1)">(1)</span> Except as provided in <a class="internal-link " href="/us/md/exec/comar/10.20.01.11#J(4)" title="">§J(4) of this regulation</a>, a claim shall not be made for any fee for services provided more than 3 years before the recipient died;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#J(2)">(2)</span> A claim under this section is a preferred claim against the estate of a deceased recipient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#J(3)">(3)</span> The claim may be waived by the Department if, in the Department's judgment, enforcement of the claim will cause substantial hardship to dependents of the deceased; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.20.01.11#J(4)">(4)</span> If a responsible relative who is liable for the cost of care of the recipient has misrepresented assets or submitted fraudulent information and, by doing so, has avoided any part of the claim for the cost of care, there is no limitation on the time in which the claim may be brought against the estate.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.20.01.12" data-order="|10|20|01|.12|" data-ref-path="10|20|01|.12" class="h__section">.12 Conflict with Regulations of the Kidney Disease Commission.</h3>
                <p>Pursuant to Health-General Article, §13-308(e), Annotated Code of Maryland, the Department is authorized, after consulting with the Commission, to adopt these regulations. Accordingly, these regulations supersede any regulations issued by the Commission that concern nonmedical issues.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.19" aria-label="Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES">
                <div class="h__ui">Previous</div>
                <span>Subtitle 19 DANGEROUS DEVICES AND SUBSTANCES</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.21" aria-label="Subtitle 21 MENTAL HYGIENE REGULATIONS">
                <div class="h__ui">Next</div>
                <span>Subtitle 21 MENTAL HYGIENE REGULATIONS</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
<p>This version of the laws and codes on this website is licensed under the <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/">CC BY-NC-SA 4.0</a> license with copyright held by the State of Maryland.</p><p>This version of the laws and codes on this website will be dedicated to the public domain under the <a href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0</a> license 180 days after publication.</p>
<p>
      Please do not scrape. Instead, bulk download the CC BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
